Valuation: Lord Global Corporation

Market Cap 5.28M 4.61M 4.34M 3.95M 7.41M 506M 7.41M 51.94M 20.02M 258M 19.84M 19.4M 832M P/E 2018 *
-
P/E 2019 -0.6x
Enterprise Value 5.89M 5.13M 4.84M 4.4M 8.26M 564M 8.27M 57.92M 22.32M 287M 22.12M 21.63M 927M EV / Sales 2018
1,290x
EV / Sales 2019 1,135x
Free-Float
25.63%
Yield 2018 *
-
Yield 2019 -
1 day+50.00%
1 week+50.00%
Current month+50.00%
1 month+50.00%
3 months+50.00%
6 months+50.00%
Current year+50.00%
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0002
0
3 years 0
Extreme 0.0002
0
5 years 0
Extreme 0.0001
0.6
10 years 0
Extreme 0
75,000
Manager TitleAgeSince
Chief Executive Officer 36 24/01/2020
Director TitleAgeSince
Chairman 36 24/01/2020
Change 5-day change 1-year change 3-year change Capi.($)
+50.00%+50.00%+50.00%+200.00% 559
+2.37%-8.31%-45.75%-20.13% 11.12B
+0.33%+2.37%+86.85%+122.88% 9.63B
-2.17%-3.86%-16.82%+46.42% 8.35B
+1.58%+11.74%-41.47%-27.04% 5.31B
+0.09%+1.91%-40.93%+33.37% 4.92B
+1.44%+0.71%-5.25%-5.25% 4.1B
+0.15%+5.94%-27.73%-2.59% 3.77B
-0.57%+2.23%+66.76%+51.27% 3.42B
-3.97%-4.29%-50.00%-30.29% 3.18B
Average +4.91%+0.95%-2.43%+36.86% 5.38B
Weighted average by Cap. +0.20%-0.15%-5.41%+26.31%

Financials

2018 2019
Net sales 2.83K 2.46K 2.32K 2.11K 3.96K 271K 3.97K 27.8K 10.72K 138K 10.62K 10.38K 445K 888 774.25 729.22 664.09 1.25K 85.07K 1.25K 8.73K 3.37K 43.34K 3.34K 3.26K 140K
Net income -6.43M -5.61M -5.28M -4.81M -9.02M -616M -9.03M -63.27M -24.39M -314M -24.17M -23.63M -1.01B -491K -428K -403K -367K -688K -47.01M -689K -4.83M -1.86M -23.95M -1.84M -1.8M -77.28M
Net Debt 651K 567K 534K 486K 912K 62.32M 913K 6.4M 2.47M 31.75M 2.44M 2.39M 102M 608K 530K 499K 454K 852K 58.22M 853K 5.98M 2.3M 29.66M 2.28M 2.23M 95.7M
Logo Lord Global Corporation
27 Health Holdings Corp., formerly Lord Global Corporation, is focused on the business development of its 27Health Inc. subsidiary. 27Health Inc. is focused on financing and marketing, healthcare-related products. The Company distributes the Virolens product in Asia, Australia, New Zealand and other Oceania countries. The Virolens system is a COVID-19 screening device based on microscopic holographic imaging and artificial intelligence (AI) software technology. It uses a digital camera attached to a microscope to analyze saliva samples, with the data run through a computer that is trained to identify the virus from other cells, delivering a result in just 20 seconds. The Virolens system was trained to recognize the COVID-19 virus particles in saliva using a range of samples of COVID-19 virus provided by virologists working on the virus at the University of Bristol.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. LRDG Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!